Health
Longevity Science
Landmark Trial: Daily Multivitamin Slows Biological Aging Markers in Seniors Over Two Years
3 sources · 8d ago
Factlen Explainer
Landmark Trial: Novel Base-Editing Gene Therapy Cures Thalassemia Patients
4 sources · 8d ago
Alzheimer's Diagnostics
Landmark Alzheimer's Blood Test Allows Primary Care Doctors to Diagnose With Specialist Accuracy
7 sources · 8d ago
More in Health
Alzheimer's DiagnosticsExplainer
Landmark Alzheimer's Blood Test Allows Primary Care Doctors to Diagnose With Specialist Accuracy
Clinical Optimists 45%Primary Care Providers 35%Cautious Ethicists 20%
7 sources · 8d ago
Alzheimer's DiagnosticsExplainer
Landmark Alzheimer's Blood Test Allows Primary Care Doctors to Diagnose With Specialist Accuracy
Clinical Optimists 45%Primary Care Providers 35%Cautious Ethicists 20%
7 sources · 8d ago
Factlen ExplainerACA Premiums
Why ACA Marketplace Premiums Are Proposed to Rise 14% in 2026
Consumer Advocates 45%Insurers and Actuaries 35%Fiscal Conservatives 20%
3 sources · 8d ago
Psychiatric GeneticsEvidence Pack
Landmark Genetic Study Finds Schizophrenia and Bipolar Disorder Share 70% of Underlying Risk
Genomic Researchers 40%Clinical Psychiatrists 35%Diagnostic Reformers 25%
4 sources · 8d ago
Supplement RegulationPolicy Shift
FDA Signals Major Overhaul of Supplement Law, May Allow Synthetic and Fermented Ingredients
Supplement Industry Advocates 44%Consumer Safety Watchdogs 31%Biotech Innovators 25%
7 sources · 8d ago
Supplement RegulationPolicy Shift
FDA Signals Major Overhaul of Supplement Law, May Allow Synthetic and Fermented Ingredients
Supplement Industry Advocates 44%Consumer Safety Watchdogs 31%Biotech Innovators 25%
7 sources · 8d ago
Factlen ExplainerGlobal Health Policy
The Evidence Debate: Why the WHO's New Traditional Medicine Strategy is Facing Backlash
Evidence-Based Medicine Advocates 40%Public Health Pragmatists 40%Traditional Medicine Practitioners 20%
6 sources · 8d ago
Factlen ExplainerGlobal Health Policy
The Evidence Debate: Why the WHO's New Traditional Medicine Strategy is Facing Backlash
Evidence-Based Medicine Advocates 40%Public Health Pragmatists 40%Traditional Medicine Practitioners 20%
6 sources · 8d ago
Multiple MyelomaTreatment De-escalation
Landmark Trial Shows Two Years of Myeloma Maintenance Therapy Is As Effective As Indefinite Treatment
Clinical Researchers 50%Patient Advocates 30%Healthcare Economists 20%
6 sources · 8d ago
Multiple MyelomaTreatment De-escalation
Landmark Trial Shows Two Years of Myeloma Maintenance Therapy Is As Effective As Indefinite Treatment
Clinical Researchers 50%Patient Advocates 30%Healthcare Economists 20%
6 sources · 8d ago
Factlen ExplainerLongevity Science
Clinical Study Finds Semaglutide Slows Biological Aging Markers, Suggesting First Longevity Effect
Longevity Researchers 40%Clinical Skeptics 35%Patient Advocates 25%
6 sources · 8d ago
Factlen ExplainerLongevity Science
Clinical Study Finds Semaglutide Slows Biological Aging Markers, Suggesting First Longevity Effect
Longevity Researchers 40%Clinical Skeptics 35%Patient Advocates 25%
6 sources · 8d ago
Food SafetyExplainer
Massive Cyclospora Outbreak Prompts Lettuce Warnings and Precautionary Menu Changes
Public Health Officials 40%Food Service Operators 30%Food Safety Advocates 30%
7 sources · 9d ago